Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of

Shamir R Mehta1, Jia Wang1, David A Wood2

  • 1Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

JAMA Cardiology
|September 21, 2022
PubMed

Insights

Complete revascularization in STEMI patients with multivessel CAD slightly improved angina-free status compared to culprit lesion-only PCI. This offers an additional health status benefit beyond reduced cardiovascular events.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Patient-Reported Outcomes

Background:

  • Multivessel coronary artery disease (CAD) with ST-segment elevation myocardial infarction (STEMI) often requires intervention.
  • Complete revascularization reduces major cardiovascular events versus culprit lesion-only percutaneous coronary intervention (PCI).
  • The impact of complete revascularization on angina-related health status in STEMI patients with multivessel CAD remains unclear.

Purpose of the Study:

  • To determine if complete revascularization improves angina status in STEMI patients with multivessel CAD.
  • To compare angina-free status between complete revascularization and culprit lesion-only PCI strategies.

Main Methods:

  • Secondary analysis of a randomized, multinational, open-label trial involving 4041 STEMI patients with multivessel CAD.
  • Patients were randomized to complete revascularization (additional PCI for significant nonculprit lesions) or culprit lesion-only PCI.
  • Angina status assessed using the Seattle Angina Questionnaire Angina Frequency (SAQ-AF) score at a median 3-year follow-up.

Main Results:

  • Complete revascularization led to a higher proportion of angina-free patients (87.5%) compared to culprit lesion-only PCI (84.3%), an absolute difference of 3.2% (P=.01).
  • The mean SAQ-AF score improved significantly in both groups, with a slightly greater improvement in the complete revascularization group (9.9 vs 8.9 points, P=.006).
  • Benefits were more pronounced in patients with nonculprit lesion stenosis severity of 80% or more.

Conclusions:

  • Complete revascularization in STEMI patients with multivessel CAD yields a modest but significant improvement in angina-free status.
  • This enhanced health status is an additional benefit to the known reduction in major cardiovascular events.
  • The findings support considering complete revascularization for improving patient-reported outcomes in this population.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
60
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
35
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
36